Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

World-class cyclists on erythropoietin.

Heuberger JA, Cohen AF.

Br J Clin Pharmacol. 2014 Mar;77(3):582. doi: 10.1111/bcp.12186. No abstract available.

2.

DOPING. Cyclists' favorite drug falls flat in trial.

Enserink M.

Science. 2016 Jul 15;353(6296):206-7. doi: 10.1126/science.353.6296.206. Epub 2016 Jul 14. No abstract available.

PMID:
27418482
3.

Little soldiers in their cardboard cells.

van Breda E, Benders J, Kuipers H.

Br J Clin Pharmacol. 2014 Mar;77(3):580-1. doi: 10.1111/bcp.12187. No abstract available.

4.

Erythropoietin doping in cycling: lack of evidence for efficacy and a negative risk-benefit.

Heuberger JA, Cohen Tervaert JM, Schepers FM, Vliegenthart AD, Rotmans JI, Daniels JM, Burggraaf J, Cohen AF.

Br J Clin Pharmacol. 2013 Jun;75(6):1406-21. doi: 10.1111/bcp.12034. Review.

5.

Peddling drugs to the pedal pushers.

[No authors listed]

Lancet. 1998 Aug 8;352(9126):415. No abstract available.

PMID:
9708742
6.

Some empirical notes on the epo epidemic in professional cycling.

Lodewijkx HF, Brouwer B.

Res Q Exerc Sport. 2011 Dec;82(4):740-54.

PMID:
22276416
7.

What is a normal red-blood cell mass for professional cyclists?

Saris WH, Senden JM, Brouns F.

Lancet. 1998 Nov 28;352(9142):1758. No abstract available.

PMID:
9848362
8.

Police find range of drugs after trawling bins used by Tour de France cyclists.

Benkimoun P.

BMJ. 2009 Oct 13;339:b4201. doi: 10.1136/bmj.b4201. No abstract available.

PMID:
19825964
9.

All doped up--and going for the gold.

Zorpette G.

Sci Am. 2000 May;282(5):20, 22. No abstract available.

PMID:
11056980
10.

[Blood doping: 2].

Cristani A, Boldrini E, Amateis E, Arioli D.

Recenti Prog Med. 2005 Jan;96(1):1-3. Italian.

PMID:
15789630
11.

Alpha-tocopherol supplementation in racing cyclists during extreme endurance training.

Braun B.

Int J Sport Nutr. 1995 Jun;5(2):165-7. No abstract available.

PMID:
7670455
12.

Doping destroys the story at the heart of cycling.

Riley S.

Nature. 2007 Sep 20;449(7160):281. No abstract available.

PMID:
17882200
13.

Erythropoietin.

Romijn JA.

N Engl J Med. 1991 Oct 17;325(16):1176-7. No abstract available.

14.

The influence of body mass in endurance bicycling.

Swain DP.

Med Sci Sports Exerc. 1994 Jan;26(1):58-63. Review.

PMID:
8133740
15.

[Putative effects of doping in cycling].

Kuipers H.

Ned Tijdschr Geneeskd. 2006 Dec 2;150(48):2643-5. Review. Dutch.

PMID:
17205940
16.

[The use of drugs to improve athletic performance].

Verheij TC.

Ned Tijdschr Geneeskd. 1997 Nov 29;141(48):2364-5. Dutch. No abstract available.

PMID:
9550839
17.

The influence of exercise on serum markers of altered erythropoiesis and the indirect detection models of recombinant human erythropoietin abuse in athletes.

Schumacher YO, Temme J, Bueltermann D, Schmid A, Berg A.

Haematologica. 2003 Jun;88(6):712-4. No abstract available.

18.

Short-term effects of prolonged strenuous endurance exercise on the level of haematocrit in amateur cyclists.

Neumayr G, Pfister R, Mitterbauer G, Gaenzer H, Joannidis M, Eibl G, Hoertnagl H.

Int J Sports Med. 2002 Apr;23(3):158-61.

PMID:
11914976
19.

[Doping in endurance sports. Survey of individual [Hb] levels can expose doping].

Ekblom B, Holmberg HC, Eriksson K.

Lakartidningen. 2001 Nov 28;98(48):5490-2, 5495-6. Swedish.

PMID:
11769364
20.

Ergogenic aids: a review of basic science, performance, side effects, and status in sports.

Tokish JM, Kocher MS, Hawkins RJ.

Am J Sports Med. 2004 Sep;32(6):1543-53. Review.

PMID:
15310585

Supplemental Content

Support Center